Subsequent to the issuance of the Original Report on May 1, 2024, the Company identified a material accounting error related to the timing of revenue recognition which impacts the Company’s condensed consolidated financial statements as of and for the three month periods ended March 31, 2024 and 2023 ("the Misstatement"). Within this report, the Company has restated all impacted financial information and footnote disclosures impacted by the Misstatement. A description of the error and its impact on the previously issued financial statements is included below. In connection with the restatement to correct this misstatement, the Company determined that it was appropriate to correct other unrelated immaterial errors.

During the first quarter of 2023, a customer cancelled two COVID-related, non-cancellable product purchase orders (“Cancelled PO’s”) in exchange for a $17.3 million one-time cash payment (the “Payment”), which was received in April 2023. At the time of cancellation, no product units had been delivered under the Cancelled PO’s and the Company had two other purchase orders from the same customer for the same product (“Open PO’s”). The Company originally accounted for the Cancelled PO’s as a single contract and recognized the $17.3 million payment as component of product revenue in the first quarter of 2023.

Subsequent to the issuance of the Original Report, the Company reassessed the accounting treatment of the Payment and concluded that the Cancelled PO’s and Open PO’s represented a combined contract such that the February 2023 transaction should have been analyzed and accounted for as a contract modification, which required the Payment to be deferred and recognized as product units were delivered under the Open PO’s. All Open PO product units were fully delivered to the customer by June 30, 2024.

The correction of the Misstatement affects certain financial statement line items in these condensed consolidated financial statements including but not limited to product revenues, income tax provision, foreign currency translation, deferred revenues, prepaid expenses, deferred taxes and earnings-per-share.

The following tables present the impact of the financial statement adjustments on the Company's previously reported condensed consolidated financial statements. The "Previously Reported" amounts in the following tables are amounts derived from the Original Report. The amounts in the columns labeled "Revenue Adjustments" represent the effect of adjustments resulting from the correction of the overstatement of revenues associated with the Payment and related tax impact. The amounts in the columns labeled "Other Adjustments" represent the effect of other adjustments that relate to other unrelated errors in previously filed financial statements that were not material, individually or in the aggregate, to those filed financial statements. The effects of both the restatement for the Revenue Adjustments and the immaterial Other Adjustments have been corrected in all impacted tables and footnotes throughout these condensed consolidated financial statements.


	Three Months Ended March 31, 2024
	As Previously Reported			Revenue Adjustments		Other Adjustments			As Restated
Revenue:
Products	$	151,310		$	1,836	$	—		$	153,146
Royalty and other revenue		36			—		—			36
Total revenue		151,346			1,836		—			153,182
Costs and operating expenses:
Cost of goods sold		76,391			—		—			76,391
Research and development		11,238			—		—			11,238
Selling, general and administrative		61,686			—		117			61,803
Contingent consideration		—			—		—			—
Total costs and operating expenses		149,315			—		117			149,432
Income from operations		2,031			1,836		(117	)		3,750
Other income (expenses):
Investment income		8,993			—		—			8,993
Interest expense		(4,891	)		—		(138	)		(5,029	)
Amortization of debt issuance costs		(483	)		—		—			(483	)
Other (expenses) income		(3,536	)		—		—			(3,536	)
Other income (expense), net		83			—		(138	)		(55	)
Income before income taxes		2,114			1,836		(255	)		3,695
Income tax provision		20			438		(59	)		399
Net income	$	2,094		$	1,398	$	(196	)	$	3,296
Earnings per share:
Basic	$	0.04		$	0.03	$	(0.01	)	$	0.06
Diluted (Note 13)	$	0.04		$	0.02	$	0.00		$	0.06
Weighted average common shares outstanding:
Basic		55,791			—		—			55,791
Diluted (Note 13)		56,531			—		—			56,531

Net income	$	2,094		$	1,398	$	(196	)	$	3,296
Other comprehensive income (loss):
Foreign currency translation adjustment		(5,281	)		147		—			(5,134	)
Comprehensive (loss) income	$	(3,187	)	$	1,545	$	(196	)	$	(1,838	)


	Accumulated Other Comprehensive Loss											Accumulated Earnings										Total Stockholders' Equity
	As Previously Reported			Revenue Adjustments			Other Adjustments		As Restated			As Previously Reported		Revenue Adjustments			Other Adjustments			As Restated		As Previously Reported			Revenue Adjustments			Other Adjustments			As Restated
	$			$			$		$			$		$			$			$		$			$			$			$
Balance at December 31, 2023		(37,431	)		(377	)		—		(37,808	)		438,849		(5,197	)		(784	)		432,868		1,971,203			(5,574	)		(784	)		1,964,845
Net income		—			—			—		—			2,094		1,398			(196	)		3,296		2,094			1,398			(196	)		3,296
Translation adjustment		(5,281	)		147			—		(5,134	)		—		—			—			—		(5,281	)		147			—			(5,134	)
Balance at March 31, 2024		(42,712	)		(230	)		—		(42,942	)		440,943		(3,799	)		(980	)		436,164		1,970,601			(4,029	)		(980	)		1,965,592


	Three Months Ended March 31, 2024
	As Previously Reported			Revenue Adjustments			Other Adjustments			As Restated
Cash flows from operating activities:
Net income	$	2,094		$	1,398		$	(196	)	$	3,296
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		16,791			—			118			16,909
Amortization of debt discount and issuance costs		3,809			—			—			3,809
Stock-based compensation		8,776			—			—			8,776
Deferred income taxes, net		(833	)		(230	)		(59	)		(1,122	)
Contingent consideration		—			—			—			—
Operating lease right of use asset amortization		(19,465	)		—			23,859			4,394
Other		(105	)		—			137			32
Changes in operating assets and liabilities, excluding impact of acquisitions:
Accounts receivable		6,653			—			—			6,653
Inventories		3,167			—			—			3,167
Prepaid expenses and other assets		(4,571	)		2,233			—			(2,338	)
Other assets		320			—			—			320
Accounts payable		(645	)		—			—			(645	)
Accrued expenses		6,381			(3,401	)		—			2,980
Operating lease liabilities		22,484			—			(23,859	)		(1,375	)
Long-term liabilities		(148	)		—			—			(148	)
Total cash provided by operating activities		44,708			—			—			44,708
Cash flows from investing activities:
Additions to capitalized software costs		(27	)		—			—			(27	)
Purchases of property, plant and equipment		(8,346	)		—			—			(8,346	)
Other investing activities		11			—			—			11
Total cash used in investing activities		(8,362	)		—			—			(8,362	)
Cash flows from financing activities:
Proceeds from exercise of stock options		945			—			—			945
Payment of tax withholding obligation on vesting of restricted stock		(7,622	)		—			—			(7,622	)
Payment of earnout consideration		(2,160	)		—			—			(2,160	)
Other financing activities		(137	)		—			—			(137	)
Total cash used in financing activities		(8,974	)		—			—			(8,974	)
Effect of exchange rate changes on cash and cash equivalents		1,922			—			—			1,922
Net increase (decrease) in cash and cash equivalents		29,294			—			—			29,294
Cash, cash equivalents and restricted cash, beginning of period		751,323			—			—			751,323
Cash and cash equivalents, end of period	$	780,617		$	—		$	—		$	780,617
Supplemental disclosure of non-cash investing and financing activities:
Assets acquired under operating leases	$	23,093		$	—		$	—		$	23,093
Fair value of shares of common stock issued for contingent consideration earnouts	$	541		$	—		$	—		$	541